Table 1 Baseline characteristics of Patients included in this study
Characteristic | Values |
|---|---|
Age, mean (SD) [years] | 62.2 (10.8) |
Pre-op CA125, median (IQR) | 305 (136-894) |
FIGO stages (3 or 4), n (%) | 45 (80.4) |
No residual disease, n (%) | 29 (51.8) |
Surgical procedures, n (%) | Â |
   Salpingo oophorectomy | 54 (96.4) |
   Omentectomy | 49 (87.5) |
   Pelvic Lymph node dissection | 45 (80.4) |
   Hysterectomy | 41 (73.2) |
   Aortic Lymph node dissection | 39 (69.6) |
   Appendicectomy | 26 (46.4) |
   Rectal resection | 13 (23.2) |
   Liver/Spleen resection | 5 (8.9) |
   Vaginectomy | 5 (8.9) |
   Small bowel resection | 4 (7.1) |
   Diaphragm | 3 (5.4) |
   Ureter | 3 (5.4) |
   Others* | 8 (14.3) |
Cell type | Â |
   Serous, n (%) | 36 (64.3) |
   Other, n (%) | 20 (35.7) |
Grade, n (%) | Â |
   1 | 4 (7.1) |
   2 | 14 (25.0) |
   3 | 38 (67.9) |
Relapse, n (%) | 29 (51.8) |
Relapse, detected by, n (%) | Â |
   CA125 alone | 14 (48.3) |
   CA125 plus any other (imaging, clinical) | 8 (27.6) |
   CA125 not elevated | 7 (24.1) |